Home/Filings/4/A/0001683168-23-007786
4/A//SEC Filing

Salkind Gene 4/A

Accession 0001683168-23-007786

CIK 0001084267other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 2:40 PM ET

Size

7.4 KB

Accession

0001683168-23-007786

Insider Transaction Report

Form 4/AAmended
Period: 2023-10-06
Salkind Gene
Director10% Owner
Transactions
  • Award

    Common Stock

    2023-10-06$0.65/sh+150,000$97,500448,535 total
  • Award

    Common Stock

    2023-10-06524,671 total
    Exercise: $0.70From: 2023-10-06Exp: 2023-11-30Common Stock (428,571 underlying)
Footnotes (3)
  • [F1]The 448,535 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee.
  • [F2]The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. Salkind has the right to convert $300,000 loan into common stock at $.70 per share or into the terms of a financing completed before November 30, 2023.
  • [F3]Not applicable.

Documents

1 file

Issuer

Mobiquity Technologies, Inc.

CIK 0001084267

Entity typeother

Related Parties

1
  • filerCIK 0001592481

Filing Metadata

Form type
4/A
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 2:40 PM ET
Size
7.4 KB